Bristol-Myers Squibb

NYSE: BMY · Real-Time Price · USD
48.47
0.66 (1.38%)
At close: Aug 15, 2025, 3:59 PM
48.50
0.07%
After-hours: Aug 15, 2025, 07:58 PM EDT

Bristol-Myers Squibb Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
1.31B 2.46B 76M 1.22B 1.68B -11.91B 1.76B 1.93B 2.08B 2.27B 2.02B 1.61B 1.43B 1.28B 2.37B 1.55B 1.06B 2.03B
Depreciation & Amortization
1.01B 1.01B 1.88B 2.59B 2.6B 2.53B 2.46B 2.44B 2.43B 2.43B 2.52B 2.59B 2.58B 2.58B 2.58B 2.73B 2.71B 2.67B
Stock-Based Compensation
137M 144M 120M 129M 125M 133M 127M 132M 137M 122M 119M 115M 116M 107M 133M 142M 157M 151M
Other Working Capital
482M -1.63B 441M 1.64B -868M -363M 1.12B 1.06B -1.45B -1.09B -716M 1.15B -872M -1.17B 14M 1.02B -583M -911M
Other Non-Cash Items
1.88B -16M 1.88B 204M 623M 12.59B 371M 286M 27M 60M -277M -143M 488M 887M 295M 228M 709M -657M
Deferred Income Tax
-437M 223M -791M -256M -331M -711M -1.33B -327M -1.09B -548M -624M -645M -782M -687M -1.27B -32M -163M 68M
Change in Working Capital
15M -1.87B 1.28B 1.71B -2.37B 198M 855M 291M -1.7B -1.36B -458M 164M -1.57B -362M -56M 649M -1.42B -435M
Operating Cash Flow
3.92B 1.95B 4.44B 5.59B 2.33B 2.83B 4.25B 4.75B 1.89B 2.97B 3.31B 3.69B 2.26B 3.81B 4.06B 5.27B 3.06B 3.82B
Capital Expenditures
-361M -260M -378M -324M -262M -284M -330M -342M -259M -278M -346M -247M -272M -253M -320M -270M -210M -173M
Cash Acquisitions
-15M 165M 286M -93M -1.1B -19.81B -340M -79M 10M 149M 374M -3.04B -275M -40M 26M -869M -164M 145M
Purchase of Investments
-621M -636M -371M -40M -84M -274M -717M -502M -355M -200M -26M -274M -1.58B -1.71B -2.07B -1.06B -1.04B -1.3B
Sales Maturities Of Investments
524M 232M 267M 238M 130M 752M 41M 513M 275M 119M 1.21B 1.48B 1.84B 2.1B 2.77B 1.23B 1.59B 1.19B
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-473M -499M -196M -219M -1.32B -19.62B -1.35B -410M -329M -210M 1.21B -2.08B -289M 95M 401M -976M 180M -143M
Debt Repayment
-585M 368M -405M -2.65B -2.8B 15.95B 2.1B -10M -124M -1.51B 136M -2.86B -2.79B 199M -114M -361M -1.12B -4.58B
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -4B -905M -250M -2.42B -585M n/a -5B -2.75B -525M -1.24B -1.77B
Dividend Paid
-1.26B -1.26B -1.22B -1.22B -1.22B -1.21B -1.16B -1.19B -1.2B -1.2B -1.15B -1.15B -1.15B -1.19B -1.1B -1.09B -1.1B -1.11B
Other Financial Acitivies
11M -103M -19M 16M -6M -97M 25M 41M 53M -92M 179M 53M 419M 333M -3M 196M 276M 172M
Financial Cash Flow
-1.84B -993M -1.64B -3.85B -4.02B 14.64B 967M -5.16B -2.17B -3.05B -3.25B -4.54B -3.52B -5.65B -3.97B -1.78B -3.18B -7.29B
Net Cash Flow
1.74B 528M 2.45B 1.6B -3.04B -2.19B 3.95B -857M -623M -277M 1.37B -3B -1.62B -1.74B 437M 2.48B 76M -3.65B
Free Cash Flow
3.56B 1.69B 4.06B 5.27B 2.06B 2.55B 3.92B 4.41B 1.63B 2.69B 2.96B 3.44B 1.99B 3.56B 3.74B 5B 2.85B 3.65B